All Stories

  1. Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts
  2. Epidemic and pandemic viral infections: impact on tuberculosis and the lung
  3. Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
  4. The Mycobacterial HBHA Protein: A Promising Biomarker for Tuberculosis
  5. Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice
  6. Can we predict tuberculosis cure? Current tools available
  7. Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables
  8. PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis
  9. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs
  10. Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease
  11. Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection
  12. A T-cell diagnostic test for cystic echinococcosis based on Antigen B peptides
  13. Long-lasting tuberculous pleurisy
  14. Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
  15. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection
  16. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis